The Australasian Leukaemia and Lymphoma Group (ALLG) Trial Centre

Funding Activity

Does something not look right? The information on this page has been harvested from data sources that may not be up to date. We continue to work with information providers to improve coverage and quality. To report an issue, use the .

Funded Activity Summary

Lymphoma, leukaemia and related cancers of the blood affect thousands of Australians, including children. The Australasian Leukaemia and Lymphoma Group, a network of clinical and laboratory haematologists, will integrate laboratory research to discover new approaches to treatment, with clinical trials to test the safety and effectiveness of the new treatments. This approach should accelerate the research and maximise patient and community benefits.

Funded Activity Details

Start Date: 01-01-2006

End Date: 01-01-2011

Funding Scheme: NHMRC Enabling Grants

Funding Amount: $790,000.00

Funder: National Health and Medical Research Council

Research Topics

ANZSRC Field of Research (FoR)

Oncology and Carcinogenesis

ANZSRC Socio-Economic Objective (SEO)

There are no SEO codes available for this funding activity

Other Keywords

best practice | bone marrow transplant | cancer chemotherapy | clinical trial